Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Brexucabtagene autoleucel injection is used to treat mantle cell lymphoma (MCL) and acute lymphoblastic leukemia (ALL) in patients who have received other cancer medicines but did not work well.
Brexucabtagene autoleucel is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize and attack your cancer cells. Before you begin treatment, talk to your doctor about the benefits of this medicine as well as the possible risks of receiving it.
This medicine is available only under a restricted distribution program called the Yescarta™ and Tecartus™ REMS (Risk Evaluation and Mitigation Strategy) Program.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2023
Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.